⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 29, 2021Arthritis Research & TherapyOpen Access

Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

ClinicalTrials.gov, NCT02552212 . Registered on 15 September 2015.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Maksymowych et al. (2021) studied this question.

synapsesocial.com/papers/69d8d19f2c39562886ae2e5f https://doi.org/10.1186/s13075-021-02650-4

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial SpondyloarthritisRCT · 2015 · 230 citations
2Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)RCT · 2012 · 539 citations
3Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK studyRCT · 2015 · 101 citations
4Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled TrialRCT · 2014 · 229 citations
5Evaluation of Diagnostic Criteria for Ankylosing SpondylitisOriginal Research · 1984 · 5,776 citations